CCN2 and Peritoneal Fibrosis: In this study, we extended these findings to a model in which intraperitoneal co-injections of TGF-β2 and recombinant human CTGF produced profound peritoneal fibrosis, abdominal adhesions, and disseminated fibrosis in vital organs, including lung, heart, kidney and liver.